Ming Hseih

Title: The Innovative Contributions of Ming Hseih

Introduction

Ming Hseih is a notable inventor based in El Monte, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing drug solubility and efficacy while minimizing side effects.

Latest Patents

Ming Hseih holds a patent for a pharmaceutical composition containing taxane nanoaggregates. This invention is directed to a pharmaceutical composition comprising sodium bicarbonate and a polymer-drug nanoaggregate that includes a polymer and a taxane. The polymer is designed to be water-soluble and features terminal groups modified with both hydrophobic and hydrophilic moieties. The taxane can include various compounds such as paclitaxel and docetaxel, which are known for their poor solubility in water. This innovative approach aims to improve drug solubility, stability, in vivo availability, and efficacy, while also reducing side effects like renal toxicity. Additionally, the patent outlines a process for producing this pharmaceutical composition and a method for treating diseases, including cancer, using the disclosed composition.

Career Highlights

Ming Hseih is currently associated with Fulgent Genetics, Inc., where he continues to advance his research and development efforts in the pharmaceutical sector. His work has garnered attention for its potential to revolutionize cancer treatment through improved drug formulations.

Collaborations

Ming has collaborated with notable colleagues such as Jing Pan and Li Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ming Hseih's contributions to pharmaceutical innovations highlight the importance of developing effective drug compositions that enhance treatment outcomes. His work exemplifies the intersection of science and technology in addressing critical health challenges.